RAPT Therapeutics, Inc. Shareholders' Equity
RAPT Therapeutics, Inc. had Shareholders' Equity of $151.98 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-06
- 2025-09-30: Stockholders' Equity Attributable to Parent $151.98M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $164.41M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $177.37M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $189.90M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-09-30 | $151.98M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $164.41M 10-Q · filed 2025-11-06 |
| 2025-03-31 | $177.37M 10-Q · filed 2025-11-06 |
| 2024-12-31 | $189.90M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $95.51M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $109.22M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $130.84M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $147.03M 10-Q · filed 2025-11-06 |
| 2023-09-30 | $172.80M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $199.68M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $220.47M 10-Q · filed 2024-11-12 |
| 2022-12-31 | $245.17M 10-K · filed 2025-03-06 |
| 2022-09-30 | $189.31M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $202.13M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $167.84M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $186.38M 10-K · filed 2024-03-07 |
| 2021-09-30 | $201.87M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $217.58M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $91.64M 10-Q · filed 2022-11-10 |
| 2020-12-31 | $104.18M 10-K · filed 2023-03-14 |
| 2020-09-30 | $110.05M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $122.61M 10-Q · filed 2021-11-10 |
| 2020-03-31 | $131.93M 10-Q · filed 2021-11-10 |
| 2019-12-31 | $73.12M 10-K · filed 2022-03-10 |
| 2019-09-30 | -$124.80M 10-Q · filed 2020-11-16 |
| 2019-06-30 | -$115.50M 10-Q · filed 2020-11-16 |
| 2019-03-31 | -$105.75M 10-Q · filed 2020-11-16 |
| 2018-12-31 | -$97.11M 10-K · filed 2021-03-11 |
| 2018-09-30 | -$88.05M 10-Q · filed 2019-12-11 |
| 2018-06-30 | -$78.11M 10-Q · filed 2019-12-11 |
| 2018-03-31 | -$70.24M 10-Q · filed 2019-12-11 |
| 2017-12-31 | -$62.41M 10-K · filed 2020-03-30 |